Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Submitted by
admin
on March 29, 2016 - 10:24pm
Source:
Yahoo/AP
News Tags:
FDA
Parkinson's Disease Psychosis
Acadia
advisory panels
pimavanserin
Headline:
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Do Not Allow Advertisers to Use My Personal information
